These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9066036)

  • 1. The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity.
    Laferrière CA; Sood RK; de Muys JM; Michon F; Jennings HJ
    Vaccine; 1997 Feb; 15(2):179-86. PubMed ID: 9066036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
    Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR
    J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm.
    Wu D; Ji S; Hu T
    Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
    Puumalainen T; Ekström N; Zeta-Capeding R; Ollgren J; Jousimies K; Lucero M; Nohynek H; Käyhty H
    J Infect Dis; 2003 Jun; 187(11):1704-8. PubMed ID: 12751027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Pinel J; Kasper DL
    J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes.
    Laferriere CA; Sood RK; de Muys JM; Michon F; Jennings HJ
    Infect Immun; 1998 Jun; 66(6):2441-6. PubMed ID: 9596700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response.
    Rodriguez ME; van den Dobbelsteen GP; Oomen LA; de Weers O; van Buren L; Beurret M; Poolman JT; Hoogerhout P
    Vaccine; 1998 Dec; 16(20):1941-9. PubMed ID: 9796048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal conjugate vaccines.
    Peeters CC; Tenbergen-Meekes AM; Haagmans B; Evenberg D; Poolman JT; Zegers BJ; Rijkers GT
    Immunol Lett; 1991 Oct; 30(2):267-74. PubMed ID: 1757114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.
    Rana R; Dalal J; Singh D; Kumar N; Hanif S; Joshi N; Chhikara MK
    Vaccine; 2015 May; 33(23):2646-54. PubMed ID: 25907408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
    Korkeila M; Lehtonen H; Ahman H; Leroy O; Eskola J; Käyhty H
    Vaccine; 2000 Jan; 18(13):1218-26. PubMed ID: 10649623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.
    Lockyer K; Gao F; Derrick JP; Bolgiano B
    Vaccine; 2015 Mar; 33(11):1345-52. PubMed ID: 25640334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
    Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid.
    Sigurdardottir ST; Vidarsson G; Gudnason T; Kjartansson S; Kristinsson KG; Jonsson S; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I
    Pediatr Infect Dis J; 1997 Jul; 16(7):667-74. PubMed ID: 9239771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide.
    Peeters CC; Tenbergen-Meekes AM; Poolman JT; Zegers BJ; Rijkers GT
    Vaccine; 1992; 10(12):833-40. PubMed ID: 1455909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity.
    Michon F; Uitz C; Sarkar A; D'Ambra AJ; Laude-Sharp M; Moore S; Fusco PC
    Clin Vaccine Immunol; 2006 Aug; 13(8):936-43. PubMed ID: 16893995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.